How do you treat staphylococcus infections in pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Staphylococcus epidermidis Infections in Pregnancy

For Staphylococcus epidermidis infections during pregnancy, intravenous nafcillin or oxacillin is recommended as first-line therapy for severe infections, while dicloxacillin is preferred for mild to moderate infections that can be treated orally.

Antibiotic Selection Based on Infection Severity

Mild to Moderate Infections

  • Oral therapy options:
    • Dicloxacillin 500mg PO every 6 hours
    • For penicillin-allergic patients (non-anaphylactic): Cephalexin 500mg PO every 6 hours
    • For penicillin-allergic patients (severe/anaphylactic): Clindamycin 300-450mg PO every 6-8 hours (if susceptibility confirmed)

Severe Infections

  • Intravenous therapy options:
    • Nafcillin 1-2g IV every 4 hours OR
    • Oxacillin 1-2g IV every 4-6 hours
    • For penicillin-allergic patients: Vancomycin 1g IV every 12 hours

Treatment Considerations by Trimester

First Trimester

  • Penicillin derivatives (nafcillin, oxacillin, dicloxacillin) are preferred due to their safety profile in pregnancy 1, 2, 3
  • Avoid tetracyclines completely as they are contraindicated in pregnancy 4
  • If susceptibility testing shows resistance to first-line agents, consult infectious disease specialists for alternative regimens

Second and Third Trimesters

  • Continue with penicillin derivatives as first-line therapy
  • For severe infections not responding to first-line therapy, consider alternative agents based on susceptibility testing

Special Considerations

Methicillin-Resistant S. epidermidis (MRSE)

  • If MRSE is suspected or confirmed:
    • Vancomycin 1g IV every 12 hours is the treatment of choice
    • Obtain susceptibility testing to guide therapy
    • Consider infectious disease consultation

Monitoring During Treatment

  • Monitor renal function with periodic creatinine measurements
  • For prolonged IV therapy, monitor complete blood count and liver function tests
  • For vancomycin therapy, consider therapeutic drug monitoring to ensure adequate levels while avoiding toxicity

Duration of Therapy

  • Uncomplicated skin and soft tissue infections: 7-10 days
  • Bacteremia: Minimum 14 days
  • Endocarditis or osteomyelitis: 4-6 weeks
  • Continue therapy until clinical resolution and laboratory markers of infection normalize

Common Pitfalls and Caveats

  1. Misidentification of the pathogen: Ensure proper specimen collection and culture techniques to differentiate S. epidermidis from contaminants, as it is a common skin commensal
  2. Inadequate duration of therapy: Complete the full course of antibiotics even if symptoms improve
  3. Failure to recognize antibiotic resistance: Always obtain susceptibility testing, especially in healthcare-associated infections
  4. Overlooking source control: Surgical drainage of abscesses or removal of infected foreign bodies may be necessary in addition to antibiotic therapy
  5. Breastfeeding considerations: Most penicillins are compatible with breastfeeding, but specific recommendations should be reviewed for each antibiotic 1, 3

Follow-up

  • Clinical reassessment within 48-72 hours of initiating therapy
  • Repeat cultures if clinical improvement is not observed
  • Consider imaging studies if deep-seated infection is suspected

By following these guidelines, clinicians can effectively manage Staphylococcus epidermidis infections in pregnant women while minimizing risks to both mother and fetus.

References

Guideline

Treatment of Group B Streptococcal Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.